CompoAtlas

Alfa B-12

Natural health product licensed in Canada

Licence holder
Enzacta Enterprises Canada Ltd.
NPN or DIN-HM
80038002
Status
Active licence
Licence date
30 November 2012
Revision date
5 May 2016
Form
Comprimé
Route of administration
Sublinguale
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Stéarate de magnésium, Carmine, D-sorbitol, Croscarmellose de sodium, D-Mannitol, Saveur de cerise, Acide citrique, Extrait de fruit de monk

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Comprimé1 day

Uses authorised in Canada

Helps the body to metabolize carbohydrates, fats and proteins. Helps to form red blood cells. Helps to reduce the risk of neural tube defects when taken daily prior to becoming pregnant and during early pregnancy. Helps in tissue formation. Helps to prevent vitamin B12, folate and vitamin B6 deficiencies.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80038002

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line